These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

222 related items for PubMed ID: 7679697

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Implication of HLA-DR residues at positions 67, 71, and 86 in interaction between HLA-DR11 and peptide HA306-320.
    Zeliszewski D, Golvano JJ, Gaudebout P, Dorval I, Freidel C, Gebuhrer L, Betuel H, Borras-Cuesta F, Sterkers G.
    J Immunol; 1993 Dec 01; 151(11):6237-47. PubMed ID: 7504016
    [Abstract] [Full Text] [Related]

  • 4. Position 71 in the alpha helix of the DR beta domain is predicted to influence peptide binding and plays a central role in allorecognition.
    Coppin HL, Carmichael P, Lombardi G, L'Faqihi FE, Salter R, Parham P, Lechler RI, de Preval C.
    Eur J Immunol; 1993 Feb 01; 23(2):343-9. PubMed ID: 8436170
    [Abstract] [Full Text] [Related]

  • 5. The inhibitory effect of altered collagen II peptide on HLA-DRB1-restricted T-cell activation.
    Cheng YJ, Zhou Q, Li ZG.
    Scand J Immunol; 2005 Mar 01; 61(3):260-5. PubMed ID: 15787743
    [Abstract] [Full Text] [Related]

  • 6. Functional analysis of DR17(DR3)-restricted mycobacterial T cell epitopes reveals DR17-binding motif and enables the design of allele-specific competitor peptides.
    Geluk A, Van Meijgaarden KE, Janson AA, Drijfhout JW, Meloen RH, De Vries RR, Ottenhoff TH.
    J Immunol; 1992 Nov 01; 149(9):2864-71. PubMed ID: 1383331
    [Abstract] [Full Text] [Related]

  • 7. Role of the polymorphic residues in HLA-DR molecules in allele-specific binding of peptide ligands.
    Marshall KW, Liu AF, Canales J, Perahia B, Jorgensen B, Gantzos RD, Aguilar B, Devaux B, Rothbard JB.
    J Immunol; 1994 May 15; 152(10):4946-57. PubMed ID: 8176213
    [Abstract] [Full Text] [Related]

  • 8. Human TCR-gamma/delta alloreactive response to HLA-DR molecules. Comparison with response of TCR-alpha/beta.
    Flament C, Benmerah A, Bonneville M, Triebel F, Mami-Chouaib F.
    J Immunol; 1994 Oct 01; 153(7):2890-904. PubMed ID: 8089476
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. MHC class II binding of peptides derived from HLA-DR 1.
    Harris PE, Liu Z, Suciu-Foca N.
    J Immunol; 1992 Apr 01; 148(7):2169-74. PubMed ID: 1545124
    [Abstract] [Full Text] [Related]

  • 11. The set of naturally processed peptides displayed by DR molecules is tuned by polymorphism of residue 86.
    Demotz S, Barbey C, Corradin G, Amoroso A, Lanzavecchia A.
    Eur J Immunol; 1993 Feb 01; 23(2):425-32. PubMed ID: 7679644
    [Abstract] [Full Text] [Related]

  • 12. Individual effects of the DR11-variable beta-chain residues 67, 71, and 86 upon DR(alpha,beta 1*1101)-restricted, peptide-specific T cell proliferation.
    McKinney JS, Fu XT, Swearingen C, Klohe E, Karr RW.
    J Immunol; 1994 Dec 15; 153(12):5564-71. PubMed ID: 7989758
    [Abstract] [Full Text] [Related]

  • 13. On the interaction of promiscuous antigenic peptides with different DR alleles. Identification of common structural motifs.
    O'Sullivan D, Arrhenius T, Sidney J, Del Guercio MF, Albertson M, Wall M, Oseroff C, Southwood S, Colón SM, Gaeta FC.
    J Immunol; 1991 Oct 15; 147(8):2663-9. PubMed ID: 1717570
    [Abstract] [Full Text] [Related]

  • 14. The importance of DR4Dw4 beta chain residues 70, 71, and 86 in peptide binding and T cell recognition.
    Signorelli KL, Watts LM, Lambert LE.
    Cell Immunol; 1995 May 15; 162(2):217-24. PubMed ID: 7743549
    [Abstract] [Full Text] [Related]

  • 15. Influence of HLA-DR genes on the production of rheumatoid arthritis-specific autoantibodies to citrullinated fibrinogen.
    Auger I, Sebbag M, Vincent C, Balandraud N, Guis S, Nogueira L, Svensson B, Cantagrel A, Serre G, Roudier J.
    Arthritis Rheum; 2005 Nov 15; 52(11):3424-32. PubMed ID: 16255019
    [Abstract] [Full Text] [Related]

  • 16. Selection of self-reactive peptides within human aggrecan by use of a HLA-DRB1*0401 peptide binding motif.
    Boots AM, Verheijden GF, Schöningh R, van Staveren CJ, Bos E, Elewaut D, de Keyser F, Veys E, Joosten I, Rijnders AW.
    J Autoimmun; 1997 Dec 15; 10(6):569-78. PubMed ID: 9451596
    [Abstract] [Full Text] [Related]

  • 17. Inhibitory effects on HLA-DR1-specific T-cell activation by influenza virus haemagglutinin-derived peptides.
    Li X, Li R, Li Z.
    Tissue Antigens; 2006 Jan 15; 67(1):45-52. PubMed ID: 16451200
    [Abstract] [Full Text] [Related]

  • 18. Structural basis of specificity and degeneracy of T cell recognition: pluriallelic restriction of T cell responses to a peptide antigen involves both specific and promiscuous interactions between the T cell receptor, peptide, and HLA-DR.
    Doherty DG, Penzotti JE, Koelle DM, Kwok WW, Lybrand TP, Masewicz S, Nepom GT.
    J Immunol; 1998 Oct 01; 161(7):3527-35. PubMed ID: 9759873
    [Abstract] [Full Text] [Related]

  • 19. Interactions between the amino-terminal domains of MHC class II molecules have a profound effect on serologic and T cell recognition: an analysis using recombinant HLA-DR/H-2E molecules.
    Barber LD, Lechler RI.
    J Immunol; 1991 Oct 01; 147(7):2346-53. PubMed ID: 1717556
    [Abstract] [Full Text] [Related]

  • 20. Ligand motifs of HLA-DRB5*0101 and DRB1*1501 molecules delineated from self-peptides.
    Vogt AB, Kropshofer H, Kalbacher H, Kalbus M, Rammensee HG, Coligan JE, Martin R.
    J Immunol; 1994 Aug 15; 153(4):1665-73. PubMed ID: 7519208
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.